PB2297: THE PREDICTIVE VALUE OF PLATELET SPECIFIC ANTIBODIES FOR THE FIRST-LINE TREATMENT EFFECT IN NEWLY DIAGNOSED PEDIATRIC ITP
Main Author: | S. Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000852016.62521.95 |
Similar Items
-
PB2298: THE RELATIONSHIP BETWEEN PLATELET SPECIFIC ANTIBODIES AND THE SEVERITY OF NEWLY DIAGNOSED PEDIATRIC ITP
by: S. Dong
Published: (2022-06-01) -
2297
by: Sandeep Nadella, et al.
Published: (2017-09-01) -
PB2311: LOW-DOSE PREDNISON AND ELTROMBOPAG COMBINATION AS FRONTLINE TREATMENT IN NEWLY DIAGNOSED ITP PATIENTS
by: S.-Y. Liu, et al.
Published: (2022-06-01) -
PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
by: Junghoon Shin, et al.
Published: (2023-08-01) -
Platelets in ITP: Victims in Charge of Their Own Fate?
by: Vivianne S. Nelson, et al.
Published: (2021-11-01)